SAN DIEGO--(BUSINESS WIRE)--Dec. 19, 2005--Cytori Therapeutics, Inc. (NASDAQ:CYTX)(Frankfurt:XMPA) announced today it has initiated trading on the NASDAQ Capital Market under the symbol CYTX.
"Our NASDAQ listing is a significant milestone for our company and will provide the company access to the U.S. capital markets and improved liquidity and value to our shareholders," said Christopher J. Calhoun, Chief Executive Officer for Cytori Therapeutics. "We are pleased to provide this dual-listing for our shareholders as we believe it will positively impact liquidity and execution for trades in our securities both domestically and internationally."
